Nanovaccine boosts immunity in sufferers of metabolic syndrome
Date | 28th, Mar 2019 |
---|---|
Source | EurekAlert - Scientific News Websites |
DESCRIPTION
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.